SIMCERE PHARMA News

SIMCERE PHARMA: Next Day Disclosure Return

Apr 25 06:17 ET

SIMCERE PHARMA: NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF ANNUAL REPORT 2023 AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT

Apr 24 07:28 ET

SIMCERE PHARMA: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF ANNUAL REPORT 2023 AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT

Apr 24 07:27 ET

SIMCERE PHARMA: 2023 ANNUAL REPORT

Apr 24 07:25 ET

SIMCERE PHARMA: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Apr 24 07:23 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 24 06:08 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 23 04:49 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 22 05:31 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 21 07:00 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 18 04:54 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 17 06:47 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 16 05:41 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 15 06:21 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 12 07:00 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 10 05:16 ET

SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - SIM0500 FOR INJECTION (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) WAS GRANTED U.S. FDA FAST TRACK DESIGNATION

Apr 9 09:35 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 9 05:18 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 8 05:43 ET

SIMCERE PHARMA: Next Day Disclosure Return

Apr 5 05:22 ET

SIMCERE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 5 04:31 ET